What's new

What criteria should you consider when developing reliable and translationally relevant disease models from edited hiPSCs?

04/16/2019

Takara Bio USA, Inc. announced today that its parent company, Takara Bio Inc., submitted a Drug Master File to the Food and Drug Administration for the liquid formulation of RetroNectin GMP grade on March 15, 2019.

04/11/2019

Discover how researchers used the powerful, new CUT&Tag method and ICELL8 technology for high-throughput, single-cell profiling of chromatin components.

03/21/2019

Researchers from Steven Henikoff's laboratory (Fred Hutchinson Cancer Research Center) have developed a novel epigenomic method, CUT&Tag (Cleavage Under Targets and Tagmentation), for high-throughput profiling of chromatin components in single cells on the ICELL8 Single-Cell System.

03/18/2019

Featured information

In this webinar, Dr. Nathalie Bolduc (Takara Bio USA, Inc.) presents data from the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian, which generates Illumina-ready sequencing libraries from 250 pg–10 ng mammalian total RNA inputs of any quality, including FFPE samples.

Our start-to-finish editing and single-cell cloning kits make human iPS cell editing routine instead of frustrating. In this video protocol, we provide step-by-step instructions for generating edited human iPS cell lines using our complete system for electroporation-based delivery of RNP complexes and single-cell cloning. This high-efficiency workflow greatly improves single-cell survival post-seeding, thanks to the Cellartis DEF-CS culture system. In addition to our electroporation-based kit, we also offer an alternate kit that uses gesicles to deliver RNP complexes.